跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
澳广 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Amoxicillin and Dicloxacillin Sodium Capsules
Approved
化学药品
Amoxicillin and Dicloxacillin Sodium Capsules
BRIGHT FUTURE PHARMACEUTICAL LABORATORIES LIMITED
🇨🇳 National Medical Products Administration
Approval Date
May 10, 2016
Approval ID
81u6EMP4Bt6
Company
BRIGHT FUTURE PHARMACEUTICAL LABORATORIES LIMITED
Type
化学药品
Approval Details
Approval Id
81u6EMP4Bt6
Approval Number
J20160039
Generic Name
阿莫西林双氯西林钠胶囊
Generic Name En
Amoxicillin and Dicloxacillin Sodium Capsules
Trade Name
澳广
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
0.375g(C16H19N3O5S 0.25g与C19H17CL2N3O5S 0.125g)
Reg Date
2016-05-10
Company Name
BRIGHT FUTURE PHARMACEUTICAL LABORATORIES LIMITED
Company Address
香港新界元朗工业村宏富街1&8号澳美制药中心
Production Company Name
BRIGHT FUTURE PHARMACEUTICAL LABORATORIES LIMITED
Production Company Address
香港新界元朗工业村宏富街8号澳美制药中心
Company Detail Path
/organization/bright-future-pharmaceutical-laboratories-limited
Production Company Detail Path
/organization/bright-future-pharmaceutical-laboratories-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 10, 2016
Approval ID
81u6EMP4Bt6
Type
化学药品
Back to NMPA Approvals